Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05773482 · ClinicalTrials.gov registry record · NA

Effects of Breathing and Attention Training (BAT) on Pain Modulation

A NA study of Fibromyalgia, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05773482: Recruiting NA study of Fibromyalgia, sponsored by University of Florida.

NCT05773482 is a NA study of Fibromyalgia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 40 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05773482, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The hypersensitivity of fibromyalgia is associated with abnormal pain modulation within the CNS, but not with peripheral or central sensitization. Many brain areas that contribute to modulation of pain are known, but their testing is complex and expensive. Quantitative sensory testing is easier to perform and repeatable. Therefore, it will be used to evaluate the effects of Breathing Attention Training (BAT) on the hypersensitivity of FM participants. BAT is a form of mindfulness meditation shown to decrease FM symptoms and possibly pain sensitivity. We hypothesize that pain modulation of chronic pain patients is improved by BAT.

Primary Outcome

Ratings of painful and non-painful stimuli in FM subjects and HC will be obtained before and after BAT or Deep Breathing. Painful stimuli will include pressure stimuli. Painless stimuli will consist of flashing light stimuli.

Conditions Studied

Interventions

  • BEHAVIORAL Breathing and Attention Training (BAT)
  • BEHAVIORAL Breathing Control

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-04-03
Est. Completion 2028-03-09
Phase NA
University of Florida

1,106 total trials

What NCT05773482 shows while recruiting

NCT05773482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Breathing and Attention Training (BAT) is the first listed.

NCT05773482 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05773482 about?

NCT05773482 is a clinical study titled "Effects of Breathing and Attention Training (BAT) on Pain Modulation". The hypersensitivity of fibromyalgia is associated with abnormal pain modulation within the CNS, but not with peripheral or central sensitization. Many brain areas that contribute to modulation of pain are known, but their testing is complex and expensive. Quantitative sensory testing is easier to p...

What is the current status of trial NCT05773482?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-03. Estimated completion is 2028-03-09.

What conditions does trial NCT05773482 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT05773482?

The interventions under investigation include: Breathing and Attention Training (BAT) (BEHAVIORAL), Breathing Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT05773482?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05773482 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05773482's enrollment target sits among peer trials

40 54th of 76 higher than 21 of 76 other Fibromyalgia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05773482, the US trial registry maintained by the National Library of Medicine. NCT05773482 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.